178 related articles for article (PubMed ID: 25900896)
21. Management of gastrointestinal stromal tumors.
Rajendra R; Pollack SM; Jones RL
Future Oncol; 2013 Feb; 9(2):193-206. PubMed ID: 23414470
[TBL] [Abstract][Full Text] [Related]
22. Descriptive nomograms of adjuvant radiotherapy use and patterns of care analysis for stage I and II endometrial adenocarcinoma: A surveillance, epidemiology, and end results population study.
Lee CM; Szabo A; Shrieve DC; Macdonald OK; Tward JD; Skidmore TB; Gaffney DK
Cancer; 2007 Nov; 110(9):2092-100. PubMed ID: 17849468
[TBL] [Abstract][Full Text] [Related]
23. Gastric GIST: a single institutional retrospective experience with surgical treatment for primary disease.
An JY; Choi MG; Noh JH; Sohn TS; Kang WK; Park CK; Kim S
Eur J Surg Oncol; 2007 Oct; 33(8):1030-5. PubMed ID: 17428635
[TBL] [Abstract][Full Text] [Related]
24. Gastrointestinal stromal tumors: evolving role of the multidisciplinary team approach in management.
Reichardt P; Morosi C; Wardelmann E; Gronchi A
Expert Rev Anticancer Ther; 2012 Aug; 12(8):1053-68. PubMed ID: 22582922
[TBL] [Abstract][Full Text] [Related]
25. Treatment guidelines for gastrointestinal stromal tumors in children and young adults.
Janeway KA; Pappo A
J Pediatr Hematol Oncol; 2012 May; 34 Suppl 2():S69-72. PubMed ID: 22525410
[TBL] [Abstract][Full Text] [Related]
26. Prevalence, Impact, and Correlates of Severe Fatigue in Patients With Gastrointestinal Stromal Tumors.
Poort H; van der Graaf WT; Tielen R; Vlenterie M; Custers JA; Prins JB; Verhagen CA; Gielissen MF; Knoop H
J Pain Symptom Manage; 2016 Aug; 52(2):265-71. PubMed ID: 27233141
[TBL] [Abstract][Full Text] [Related]
27. [New prospective on adjuvant treatment for gastrointestinal stromal tumors].
Pan ZZ; Wu XJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):212-5. PubMed ID: 23536337
[TBL] [Abstract][Full Text] [Related]
28. Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts.
Joensuu H; Vehtari A; Riihimäki J; Nishida T; Steigen SE; Brabec P; Plank L; Nilsson B; Cirilli C; Braconi C; Bordoni A; Magnusson MK; Linke Z; Sufliarsky J; Federico M; Jonasson JG; Dei Tos AP; Rutkowski P
Lancet Oncol; 2012 Mar; 13(3):265-74. PubMed ID: 22153892
[TBL] [Abstract][Full Text] [Related]
29. [Early results of the surgical management of gastrointestinal stromal tumors (gist)--the experience of the 3rd surgical unit].
Grecu F; Lapuşneanu A; Ferariu D; Volovăţ C; Pricop A; Scripcariu V; Diaconu C
Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):506-14. PubMed ID: 23077945
[TBL] [Abstract][Full Text] [Related]
30. Population variations in the initial treatment of non-small-cell lung cancer.
Potosky AL; Saxman S; Wallace RB; Lynch CF
J Clin Oncol; 2004 Aug; 22(16):3261-8. PubMed ID: 15310770
[TBL] [Abstract][Full Text] [Related]
31. Management of localized gastrointestinal stromal tumors and adjuvant therapy with imatinib.
López RL; del Muro XG
Anticancer Drugs; 2012 Jun; 23 Suppl():S3-6. PubMed ID: 22739667
[TBL] [Abstract][Full Text] [Related]
32. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
Mariotto AB; Feuer EJ; Harlan LC; Abrams J
J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
[TBL] [Abstract][Full Text] [Related]
33. Gastrointestinal stromal tumor surgery and adjuvant therapy.
Grignol VP; Termuhlen PM
Surg Clin North Am; 2011 Oct; 91(5):1079-87. PubMed ID: 21889030
[TBL] [Abstract][Full Text] [Related]
34. Are many community hospitals undertreating breast cancer?: lessons from 24,834 patients.
Gutierrez JC; Hurley JD; Housri N; Perez EA; Byrne MM; Koniaris LG
Ann Surg; 2008 Aug; 248(2):154-62. PubMed ID: 18650623
[TBL] [Abstract][Full Text] [Related]
35. Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resection.
Rutkowski P; Wozniak A; Dębiec-Rychter M; Kąkol M; Dziewirski W; Zdzienicki M; Ptaszynski K; Jurkowska M; Limon J; Siedlecki JA
Cancer; 2011 Nov; 117(21):4916-24. PubMed ID: 21456019
[TBL] [Abstract][Full Text] [Related]
36. Current incidence and outcomes of gastrointestinal mesenchymal tumors including gastrointestinal stromal tumors.
Perez EA; Livingstone AS; Franceschi D; Rocha-Lima C; Lee DJ; Hodgson N; Jorda M; Koniaris LG
J Am Coll Surg; 2006 Apr; 202(4):623-9. PubMed ID: 16571433
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of adjuvant imatinib in patients with gastrointestinal stromal tumor: results of a population-based, matched-cohort study.
Hatoum HT; Lin SJ; Sasane M; Trent JC
Curr Med Res Opin; 2012 May; 28(5):805-14. PubMed ID: 22506625
[TBL] [Abstract][Full Text] [Related]
38. Validation of the Joensuu risk criteria for primary resectable gastrointestinal stromal tumour - the impact of tumour rupture on patient outcomes.
Rutkowski P; Bylina E; Wozniak A; Nowecki ZI; Osuch C; Matlok M; Switaj T; Michej W; Wroński M; Głuszek S; Kroc J; Nasierowska-Guttmejer A; Joensuu H
Eur J Surg Oncol; 2011 Oct; 37(10):890-6. PubMed ID: 21737227
[TBL] [Abstract][Full Text] [Related]
39. [Gastrointestinal stromal tumors (GIST)].
Reichardt P; Pink D; Mrozek A; Lindner T; Hohenberger P
Z Gastroenterol; 2004 Apr; 42(4):327-31. PubMed ID: 15095124
[TBL] [Abstract][Full Text] [Related]
40. Insurance status and the use of guideline therapy in the treatment of selected cancers.
Harlan LC; Greene AL; Clegg LX; Mooney M; Stevens JL; Brown ML
J Clin Oncol; 2005 Dec; 23(36):9079-88. PubMed ID: 16301598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
